欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Endocrinology/Hormones > PZM-21

浏览历史

S88547

PZM-21

源叶(MedMol) 98%
  • 英文名:
  • 1-((S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea
  • 别名:
  • CAS号:
  • 1997387-43-5
  • 分子式:
  • C19H27N3O2S
  • 分子量:
  • 361.50158
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S88547-1mg 98% ¥610.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S88547-5mg 98% ¥1310.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S88547-10mg 98% ¥1940.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S88547-50mg 98% ¥4600.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM
  • 靶点: EC50: 1.8 nM (μ opioid receptor);OpioidReceptor
  • 体外研究:
    PZM21 has no detectable κOR or nociceptin receptor agonist activity-it is actually an 18 nM κOR antagonist-while it is a 500-fold weaker δOR agonist, making it a selective μOR agonist. At hERG, PZM21 has an IC50 of between 2 and 4 μM, 500- to 1,000-fold weaker than its potency as a μOR agonist. Signalling by PZM21 and other μOR agonists appears to be mediated primarily by the heterotrimeric G protein Gi/o, as its effect on cAMP levels is eliminated by pertussis toxin and no activity is observed in a calcium release assay
  • 体内研究:
    PZM21 is a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment. PZM21 is efficacious for the affective component of analgesia versus the reflexive component and is devoid of respiratory depression in mice at equi-analgesic doses. PZM21 displays dose-dependent analgesia in a mouse hotplate assay, with a per cent maximal possible effect (% MPE) of 87% reached 15 min after administration of the highest dose of drug tested.PZM21 has a long-lasting analgesic effect on CNS mediated-pain responses, but does not cause respiratory depression and constipation, two key side effects of opioid agonists
  • 参考文献:
    1. Manglik A, et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature. 2016 Sep 8;537(7619):185-190. 2. Kostic M, et al. Biasing Opioid Receptors and Cholesterol as a Player in Developmental Biology. 3. Araldi D, et al. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat. Neuroscience. 2018 Oct 17;394:60-71.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20°C
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.766 ml 13.831 ml 27.662 ml
    5 mM 0.553 ml 2.766 ml 5.532 ml
    10 mM 0.277 ml 1.383 ml 2.766 ml
    50 mM 0.055 ml 0.277 ml 0.553 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。